19
Apr

Dawn Scardino named 2012 LLS Woman of the Year

Dawn Scardino, Coordinator of Academic Services in the Department of Medical Oncology, was named the 2012 Leukemia & Lymphoma Society’s Woman of the Year for the eastern Pennsylvania Chapter. Dawn took the top recognition for raising almost $27,000 in a 10-week fundraising “race” that began on Jan. 30 and ended on April 12.  Four women …

17
Apr

Kimmel Cancer Center Founding Directors Portrait Unveiled

A portrait of Dr. Carlo Croce, the founding Director of the Jefferson Kimmel Cancer Center, painted by Philadelphia artist Martha Erlebacher, was unveiled on Tuesday, April 10, 2012, at 4:00 PM in the Bluemle Life Sciences Building. Martha Mayer Erlebacher has been recognized as one of the leading representational figurative and still-life artists in America …

5
Apr

Edith Mitchell, M.D., FACP, Named 2012 Recipient of ASCO Humanitarian Award

Edith  Mitchell, M.D., FACP, a medical oncologist at Thomas Jefferson University Hospital and Jefferson’s Kimmel Cancer Center (KCC) and Clinical Professor of Medicine and Medical Oncology in the Department of Medical Oncology at Jefferson Medical College of Thomas Jefferson University, has been named the 2012 recipient of the American Society of Clinical Oncology (ASCO) Humanitarian …

5
Apr

Ovarian, Glioblastoma & Non-Small Cell Lung Cancer: Jefferson Researchers Present at AACR

Several researchers from Jefferson’s Kimmel Cancer Center presented abstracts at the American Association for Cancer Research Annual Meeting 2012 in Chicago. Some of those findings include: HuR and Ovarian Cancer Silencing HuR may be a promising therapeutic approach for the treatment of ovarian cancer, according to an abstract presented at AACR by researchers from Thomas …

3
Apr

AACR: New Biomarker to Identify Hepatitis B-Infected Patients at Risk for Liver Cancer

CHICAGO— Hepatitis B-infected patients with significantly longer telomeres—the caps on the end of chromosomes that protect our genetic data— were found to have an increased risk of getting liver cancer compared to those with shorter ones, according to findings presented by researchers at Jefferson’s Kimmel Cancer Center at the American Association for Cancer Research (AACR) …

3
Apr

AACR: Eliminating the ‘Good Cholesterol’ Receptor May Fight Breast Cancer

CHICAGO— Removing a lipoprotein receptor known as SR-BI may help protect against breast cancer, as suggested by new findings presented at the American Association for Cancer Research Annual Meeting 2012 by Jefferson’s Kimmel Cancer Center researchers. In vitro and mouse studies revealed that depletion of the SR-BI resulted in a decrease in breast cancer cell …

29
Mar

Dr. Leonard Gomella, Program Director for IPCC in New York

Leonard G. Gomella, M.D., FACS, Chair of Urology at Thomas Jefferson University Hospital and Director of Clinical Affairs at the Kimmel Cancer Center at Jefferson, will serve as the Program Director for the Fifth Annual Interdisciplinary Prostate Cancer Congress (IPCC) at the New York Marriott East Side in New York City on March 31. This …

27
Mar

Jefferson Physicians Host Bilingual Health Education Session for the Annual Latinas United for the Cure

On Saturday, March 24, physicians from Jefferson’s Kimmel Cancer Center hosted a health education session entitled “The Basics and Beyond: Empowering all Latinas to Fight Breast Cancer” in both English and Spanish, as part of a free Komen Philadelphia event for the Latina community in Philadelphia and surrounding areas. Edith Mitchell, M.D., FACP, of Jefferson’s …

26
Mar

Jefferson Graduate Student Receives Joanna M. Nicolay Melanoma Foundation ‘Research Scholar Award’

Kevin Basile, a Thomas Jefferson University graduate student in the Genetics Ph.D. Program, was one of nine students from leading cancer centers across the U.S. to receive a $10,000 “Research Scholar Award” from the Joanna M. Nicolay Melanoma Foundation (JMNMF) for his exceptional research work. Two members of the board of directors for JMNMF, including …

20
Mar

Biomarker Links Clinical Outcome with New Model of Lethal Tumor Metabolism

Researchers at the Kimmel Cancer Center at Jefferson have demonstrated for the first time that the metabolic biomarker MCT4 directly links clinical outcomes with a new model of tumor metabolism that has patients “feeding” their cancer cells.  Their findings were published online March 15 in Cell Cycle. To validate the prognostic value of the biomarker, …

15
Mar

Kimmel Cancer Center “All Hands Meeting”

The Kimmel Cancer Center held it’s quarterly “All Hands” meeting on March 14, 2012. Dr. Richard Pestell, Director of the Kimmel Cancer Center, delivered his quarterly “State of the Cancer Center” address. Awards were presented in 4 categories. The Administration/Wings Award was presented to Steven McKenzie, MD, PhD. The Basic Science Award was presented to …

15
Mar

Kimmel Cancer Center “All Hands Meeting”

The Kimmel Cancer Center held it’s quarterly “All Hands” meeting on December 23, 2011. Dr. Richard Pestell, Director of the Kimmel Cancer Center, delivered his quarterly “State of the Cancer Center” address. Awards were presented in six categories. The Administration Award was presented to Jeanine Voll. The Basic Science Award was presented to Agnieszka Witkiewicz, …

13
Mar

Rawls Palmer Progress in Medicine Award Presented to Dr. Scott A. Waldman

Scott A. Waldman, M.D., Ph.D., will receive the American Society for Clinical Pharmacology and Therapeutics (ASCPT) Rawls–Palmer Progress in Medicine Award at the 2012 Annual Meeting on March 16. Established in 1978 by Dr. W. B. Rawls, the award recognizes scientists who have implemented progressive research techniques and tools to improve patient care. ASCPT will …

28
Feb

A New Battlefront: Symposium at Jefferson’s Kimmel Cancer Center to Tackle Geriatric Oncology

Approaches to treating elderly cancer patients are evolving as more of the population ages and the need for specialized care becomes more evident. To address these issues and others, national thought leaders in geriatric oncology will gather at a unique symposium at the Kimmel Cancer Center at Jefferson (KCC) in Philadelphia on Friday, March 9, …

22
Feb

PCF Young Investigator Award Goes to Jefferson Researcher

Heather Montie, Ph.D., a post-doctoral research fellow in the Department of Biochemistry and Molecular Biology, has received a Prostate Cancer Foundation Young Investigator Award for her work with androgen receptor (AR) acetylation and its role in castration-resistant prostate cancer. Young Investigator awards are designed to promote long-term careers in the field of prostate cancer by …

22
Feb

Dr. Renato V. Iozzo receives an honorary degree from Semmelweis University in Budapest, Hungary

Congratulations to Renato V. Iozzo, M.D., a Professor of Pathology and Cell Biology, and Professor of Biochemistry & Molecular Biology, Thomas Jefferson University, for receiving an honorary degree (Doctor Honoris Causa) from Semmelweis University in Budapest, Hungary. Dr. Iozzo received this award in November 2011 in recognition for his contributions to the field of Matrix …

21
Feb

Stronger Intestinal Barrier May Prevent Cancer in the Rest of the Body, New Study Suggests

A leaky gut may be the root of some cancers forming in the rest of the body, a new study published online Feb. 21 in PLoS ONE by Thomas Jefferson University researchers suggests. It appears that the hormone receptor guanylyl cyclase C (GC-C)—a previously identified tumor suppressor that exists in the intestinal tract—plays a key …

16
Feb

Jefferson’s Kimmel Cancer Center Establishes Center to Eliminate Cancer Disparities

PHILADELPHIA—In an effort to reduce and eventually eliminate cancer disparities among adults in the Philadelphia region, the Kimmel Cancer Center at Jefferson has established the Center to Eliminate Cancer Disparities. Edith P. Mitchell, M.D., FACP, a medical oncologist at Thomas Jefferson University Hospital and Clinical Professor of Medicine and Medical Oncology in the Department of …

Page 1 of 21